3648 results for «636»

Filter By

3648 results

DCB - Going beyond in-stent restenosis

20 May 2026 – From EuroPCR 2026

This session examines the expanding role of drug-coated balloons (DCB) beyond in-stent restenosis, including treatment of acute coronary syndromes, calcified lesions, and bifurcations. It reviews current evidence supporting DCB-based revascularization and outlines essential procedural steps to optimize outcomes.

Prognostics elements on multivessel disease and coronary artery disease

20 May 2026 – From EuroPCR 2026

This session examines key prognostic elements in multivessel and coronary artery disease, featuring studies on mechanical circulatory support across LDL-C levels, biomarkers impacting periprocedural myocardial infarction, autologous cell therapy outcomes for refractory angina, and novel risk stratification indices. It also addresses prognosis in cancer patients and...

Reliability and application of angio-based physiology in daily work

20 May 2026 – From EuroPCR 2026

This session evaluates the reliability and clinical application of angiography-based physiological assessments in daily practice. Topics include comparisons of angiography-derived microvascular resistance and flow metrics with invasive methods, reproducibility of quantitative flow ratio (QFR), and its correlation with symptom burden and other imaging modalities.

Lost, crushed, fractured: stent complications in real life

20 May 2026 – From EuroPCR 2026

This session addresses real-world challenges of stent complications including loss, crushing, and fracture during PCI. Through case-based discussions, it explores complex scenarios such as stent dislodgement, embolisation, and management strategies when initial plans evolve into complicated realities.

Lost, crushed, fractured: stent complications in real life

Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions

08 Jan 2025

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

Author

Bruno Scheller
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions

Robocath demonstrates feasibility of robotic carotid stenting in ‘CARE’ clinical trial conducted at Rennes University Hospital

19 Oct 2023

COVID-19: safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2 (AstraZeneca/Oxford)

02 Jan 2021

Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability

COVID-19: safety and efficacy of the ChAdOx1 nCoV-19 vaccine

Portico with FlexNav TAVI system: enhancing innovative technology to optimize patient outcomes and physician experience

05 May 2020

Real-world case report illustrating the benefits of the Portico with FlexNav TAVI system.

Real-world case report illustrating the benefits of the Portico with FlexNav TAVI system.
Didn’t find what you were looking for?